Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy

Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy

Ischemic stroke is the most common type of stroke and thrombolytic therapy is the only approved treatment. However, current thrombolytic therapy with tissue plasminogen activator (tPA) is often hampered by the increased risk of hemorrhage. Plasmin, a direct fibrinolytic, has a significantly superior...

Full description

Bibliographic Details
Main Authors: Ramsha Aamir, Cameron Fyffe, Netanel Korin, Daniel A. Lawrence, Enming J. Su, Mathumai Kanapathipillai
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
plasmin
nanoformulation
ischemic stroke
fibrinolysis
heparin
Online Access:https://www.mdpi.com/1422-0067/22/21/11477

Internet

https://www.mdpi.com/1422-0067/22/21/11477

Similar Items